ARTICLE | Company News
Pfizer, Catholic University Leuven deal
September 27, 2010 7:00 AM UTC
The university granted Pfizer exclusive, worldwide rights to develop and commercialize ledgins to treat HIV infection. Ledgins are compounds which inhibit the interaction between viral integrase and t...